MOFISCA Trademark

Trademark Overview


On Monday, November 16, 2020, a trademark application was filed for MOFISCA with the United States Patent and Trademark Office. The USPTO has given the MOFISCA trademark a serial number of 90322030. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Thursday, August 1, 2024. This trademark is owned by GW Research Limited. The MOFISCA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and veterinary preparations and substances for the treatment of neurological conditions, disorders, and diseases; pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, chron's disease, alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; Pharmaceu...
mofisca

General Information


Serial Number90322030
Word MarkMOFISCA
Filing DateMonday, November 16, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateThursday, August 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 21, 2021

Trademark Statements


Goods and ServicesPharmaceutical and veterinary preparations and substances for the treatment of neurological conditions, disorders, and diseases; pharmaceutical preparations and substances for the treatment of pain, neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer and cancer symptoms, perioperative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, hypoxic-ischaemic encephalopathy, symptoms of neurogenic disorders, movement disorders, psychotic disorders, diseases of the central nervous system, stroke and head injuries, motion sickness and chemically induced sickness, psychiatric illnesses, post-traumatic stress disorder, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, chron's disease, alzheimer's disease, bone disorders, inflammatory disorders, sleep and sleep disorders, and drug, alcohol, and nicotine abuse; Pharmaceutical preparations and substances for the treatment of neurological conditions, disorders, and diseases; herbs for medicinal purposes; medicinal herbs; medicinal oils; Medicinal infusions for treating neurological conditions, disorders, and diseases; Pure extracts of medicinal plants and herbs for medical purposes; Dietetic foods adapted for medical purposes; herb teas for medicinal purposes; plant extracts for pharmaceutical purposes
Translation of Words in MarkThe wording MOFISCA has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, January 15, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGW Research Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCambridge CB249BZ
GB

Party NameGW Research Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCambridge CB249BZ
GB

Trademark Events


Event DateEvent Description
Thursday, November 19, 2020NEW APPLICATION ENTERED
Monday, April 26, 2021ASSIGNED TO EXAMINER
Monday, May 3, 2021NON-FINAL ACTION WRITTEN
Monday, May 3, 2021NON-FINAL ACTION E-MAILED
Monday, May 3, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 15, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 15, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, September 15, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 15, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 2, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 1, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 1, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Sunday, November 14, 2021EXAMINERS AMENDMENT -WRITTEN
Sunday, November 14, 2021EXAMINER'S AMENDMENT ENTERED
Sunday, November 14, 2021EXAMINERS AMENDMENT E-MAILED
Sunday, November 14, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, November 15, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 21, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 8, 2022SOU TEAS EXTENSION RECEIVED
Monday, August 8, 2022SOU EXTENSION 1 FILED
Monday, August 8, 2022SOU EXTENSION 1 GRANTED
Wednesday, August 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 13, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, February 15, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, February 15, 2023SOU EXTENSION 2 FILED
Wednesday, February 15, 2023SOU EXTENSION 2 GRANTED
Friday, February 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 13, 2023SOU EXTENSION 3 FILED
Thursday, July 13, 2023SOU EXTENSION 3 GRANTED
Thursday, January 18, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 18, 2024SOU EXTENSION 4 FILED
Thursday, January 18, 2024SOU EXTENSION 4 GRANTED
Thursday, August 1, 2024SOU TEAS EXTENSION RECEIVED
Thursday, August 1, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 1, 2024SOU EXTENSION 5 FILED
Thursday, August 1, 2024SOU EXTENSION 5 GRANTED
Saturday, July 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED